Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 2, 1996, Pages 28-30

  Wolfram, G ^a   Sitter, T ^b   Gottsmann, M ^c   Gerzer, R ^a   Schiffl, H ^b  

^a Inst für Werkstoff Forschung   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Department of Nephrology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP;

CONFERENCE PAPER; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0029900177     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp2.28     Document Type: Conference Paper

References (13)

1. Lauster F, Heim JM, Drummer C, Fülle HJ, Gerzer R, Schiffl H. Plasma cGMP level as a marker of hydration state in renal replacement therapy. Kidney Int 1993; 43 (Suppl 41): S57-S59
2. Leunissen KML, Kouw P, Kooman JP et al. New techniques to determine fluid status in hemodialyzed patients. Kidney Int 1993; 43 (Suppl 41): S50-S56
3. Lauster F, Gerzer R, Weil J, Fülle HJ, Schiffl H. Assessment of dry body-weight in hemodialysis patients by the biochemical marker cGMP. Nephrol Dial Transplant 1990; 5: 356-361
4. Lettgcn B, Bald M, Vallee H, Bonzel KE, Rascher W. Atrial natriuretic peptide and cyclic 3′5′-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure. Pediatr Nephrol 1992; 6: 60-64
5. Lauster F, Fülle HJ, Gerzer R, Schiffl H. The postdialytic plasma cyclic guanosine 3′5′-monophosphate level as a measure of fluid overload in chronic hemodialysis. J Am Soc Nephrol 1992; 2: 1451-1454
6. Kouw PM, Kooman JP, Cheriex EC, Olthof CG, De Vries PMJM, Leunissen KML. Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 1993; 4: 98-104
7. Lauster F, Heim JM, Drummer C, Gerzer R, Schilfl H. Plasma ANP and cGMP levels in CAPD patients. Contrib Nephrol 1993; 101: 44-50
8. Hornberger JC, Petersen J. Atrial natriuretic peptide, renal failure and dialysis. Semin Dial 1990; 3: 178-181
9. Plum J, Grabensee B. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. J Internal Med 1991; 229: 209-216
10. Raine AEG, Bock A, Müller FB et al. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant 1989; 4: 222-227
11. Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis. Clin Nephrol 1992; 37: 198-203
12. Saxenhofer H, Gnädinger MP, Weidmann P et al. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int 1987; 32: 554-561
13. Kooman JP, Kouw P, Cheriex E et al. Is cGMP a reliable tool to assess dry weight in hemodialysis patients? (abstract) Nephrol Dial Transplant 1991; 6: 803